The Chinese government has discouraged companies and government-funded data centers from buying Nvidia’s chips.
The next few years of projected revenues in the pharma space have more holes in them than industry CEOs’ favorite golf ...
The company is planning to add 10 target-maturity ETFs. Vanguard and State Street have also moved to fill out their ...
With more than $1.4 trillion in flows and more than 1,000 product launches, it’s safe to say the industry is booming.
Wall Street has a new nighttime routine, and it’s not about remembering to wear a retainer.
It’s easy to recognize the folly of trying to predict the market, but there are still useful predictions to offer.
Can Kalshi and Polymarket become the massive, all-purpose financial vehicles envisioned by backers or will they be disrupted by regulators?